Press Releases
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Oct 28, 2016
NEW YORK--(BUSINESS WIRE)-- PAVmed Inc. (Nasdaq:PAVM, PAVMW), a highly differentiated, multi-product medical device company, today announced that the company has filed a registration statement on...
-
Sep 20, 2016
NEW YORK--(BUSINESS WIRE)-- PAVmed Inc. (Nasdaq:PAVM), a highly differentiated, multi-product medical device company, today announced that Lishan Aklog, M.D., PAVmed’s Chairman and Chief...
-
Sep 7, 2016
NEW YORK--(BUSINESS WIRE)-- PAVmed Inc. (Nasdaq: PAVM), a highly differentiated, multi-product medical device company, today announced that Lishan Aklog, M.D., PAVmed’s Chairman and Chief...
-
Aug 16, 2016- Conference Call to be Held August 17th-
NEW YORK--(BUSINESS WIRE)-- PAVmed Inc. (Nasdaq:PAVM) (“PAVmed” or the “Company”), a highly-differentiated multi-product medical device company, today announced financial results for the...
-
Aug 12, 2016
NEW YORK--(BUSINESS WIRE)-- PAVmed Inc. (Nasdaq:PAVM), a highly differentiated, multi-product medical device company, today announced that the Company will host a conference call on August 17,...
-
Jul 26, 2016-Common Stock (Nasdaq:PAVM) and Warrants (Nasdaq:PAVMW) will trade separately-
NEW YORK--(BUSINESS WIRE)-- PAVmed Inc. (Nasdaq:PAVMU), a highly differentiated, multi-product medical device company, announced today that the common stock and warrants underlying the units sold...
-
Jul 26, 2016
NEW YORK--(BUSINESS WIRE)-- PAVmed Inc. (Nasdaq:PAVMU), a highly differentiated, multi-product medical device company, announced today that Jan David Wald, Ph.D., Senior Research Analyst at The...
-
Jul 14, 2016-Commercialization of PortIO™ implantable vascular access device anticipated in 2017-
NEW YORK--(BUSINESS WIRE)-- PAVmed Inc. (Nasdaq:PAVMU), a highly differentiated, multi-product medical device company, announced today that it has set a Q4 2016 timeline for FDA 510(k) submission...
Jun 22, 2016- Device designed to revolutionize treatment of Carpal Tunnel Syndrome -NEW YORK--(BUSINESS WIRE)-- PAVmed Inc. (Nasdaq:PAVMU), an innovative multi-product medical device company, today announced the successful completion of a pre-clinical human cadaver study,...
-
May 26, 2016
NEW YORK--(BUSINESS WIRE)-- PAVmed Inc. (Nasdaq:PAVMU), an innovative, multi-product medical device company developing and commercializing a diversified pipeline of innovative products utilizing a...